Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EY5A
|
|||
| Former ID |
DIB014187
|
|||
| Drug Name |
VLTS-587
|
|||
| Synonyms |
Gene therapy (IL-2, cLipid) iv, Valentis; Gene therapy (interleukin-2, cLipid) iv, Valentis
Click to Show/Hide
|
|||
| Indication | Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Discontinued in Phase 2 | [1] | |
| Company |
Valentis Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008879) | |||
| REF 2 | CN patent application no. 101039956, Cell surface glycoprotein. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.